RBC Europe’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-3
| Closed | -$7K | – | 625 |
|
2022
Q1 | $7K | Buy |
+3
| New | +$7K | ﹤0.01% | 551 |
|
2021
Q4 | – | Sell |
-3
| Closed | -$20.3K | – | 675 |
|
2021
Q3 | $20.3K | Hold |
3
| – | – | ﹤0.01% | 781 |
|
2021
Q2 | $30.4K | Hold |
3
| – | – | ﹤0.01% | 710 |
|
2021
Q1 | $28.1K | Buy |
+3
| New | +$28.1K | ﹤0.01% | 679 |
|